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Classical and plasmacytoid dendritic cells (DC) play important roles in the defense against
murine and human infections with herpes simplex virus (HSV). So far, CD8a expression
has only been reported for murine DC. CD8a+ DC have prominent cross-presenting
activities, which are enhanced by murine CD8a+ PDC. The human orthologue of murine
CD8a+ DC, the CD141 (BDCA3)+ DC, mainly cross-present after TLR3 ligation. We
report here the serendipitous finding that a subset of human PDC upregulates CD8a
upon HSV-1 stimulation, as shown by gene array and flow cytometry analyses. CD8a, not
CD8ß, was expressed upon exposure. Markers of activation, migration, and costimulation
were upregulated on CD8a-expressing human PDC. In these cells, increased cytokine
and chemokine levels were detected that enhance development and function of T, B, and
NK cells, and recruit immature DC, monocytes, and Th1 cells, respectively. Altogether,
human CD8a+ PDC exhibit a highly activated phenotype and appear to recruit other
immune cells to the site of inflammation. Further studies will show whether CD8a-
expressing PDC contribute to antigen cross-presentation, which may be important for
immune defenses against HSV infections in vitro and in vivo.
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Introduction
Since Ralph Steinman first described a new subset of cells characterized by tree-like processes in
1973 (Steinman and Cohn, 1973), knowledge about dendritic cells (DC) in mice and humans has
grown exponentially. These cells were originally identified as important players in the defense against
“foreign” pathogens, but it turns out that they are similarly crucial in initiating immune responses
against tumor-associated antigens (Vacchelli et al., 2013). ImmatureDCengulf extracellular antigens,
but in the absence of appropriate danger signals, they induce peripheral tolerance. Only after
appropriate activation, DC release cytokines and chemokines, undergo a maturation process, and
migrate toward secondary lymphatic tissues to induce cytotoxic responses by other immune cells
(Palucka and Banchereau, 2012; Merad et al., 2013).
In this perspective paper, we will focus on the role of CD8a-expressing DC. CD8 serves as useful
subset marker for murine DC, which are highly efficient in cross-presenting foreign, self, and—most
Abbreviations: DC, dendritic cells; HSV, Herpes simplex virus; IFN, interferon; IL, interleukin; PBMC, peripheral
blood mononuclear cells; PDC, plasmacytoid dendritic cells.
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likely—tumor-associated antigens, although evidence is lacking
that CD8 expression plays any role in the development and
function of these cells (Shortman and Heath, 2010). So far,
CD8 expression on human DC has not been reported (Naik,
2008). However, we report here a serendipitous finding of CD8a
expression on human plasmacytoid dendritic cells (PDC) after
stimulation with herpes simplex virus type 1 (HSV-1), which
characterizes a highly activated subset of PDC. We will discuss
how the knowledge about CD8a-expressing murine DC may
translate into functions of CD8a-expressing human PDC. For the
background of this topic, the reader is referred to excellent review
articles by respected colleagues (Villadangos and Young, 2008;
Shortman and Heath, 2010; Joffre et al., 2012; Nierkens et al.,
2013; Bedoui and Greyer, 2014; Boltjes and van Wijk, 2014).
Murine CD8a+ DC: Prominent
Cross-presentation
In the murine system, several different DC populations exist:
lymphoid-organ resident CD8a+ or CD8a– DC; migratory der-
mal CD103+ or CD103– DC, which migrate to lymphatic tissue;
Langerhans cells in the skin; inflammatory DC, which develop
from monocytes; and PDC (Vremec et al., 1992; Bursch et al.,
2007; Ginhoux et al., 2007, 2009; Leon et al., 2007; Poulin et al.,
2010; Joffre et al., 2012). CD8a is a marker for lymphoid tissue-
residentDC,whichmake up roughly 20%of spleenDCand 70%of
thymic DC, whereas only 0.2% of peripheral blood mononuclear
cells are CD8a+ DC (Crowley et al., 1989; Vremec et al., 2000;
Donnenberg et al., 2001; Henri et al., 2001; Shortman and Heath,
2010). These cells express a CD8aa homodimer rather than the
CD8aß heterodimer onT cells (Vremec et al., 1992, 2000). Precur-
sors of CD8a+ DCmay lack CD8 expression (Martinez del Hoyo
et al., 2002). Apart from the classical CD8a+ DC population, this
molecule is expressed by murine PDC in the spleen (O’Keeffe
et al., 2002) and other migratory DC after activation (Anjuere
et al., 1999, 2000; Merad et al., 2000; Henri et al., 2001). Mice
with a knock-out for interferon regulatory factor (IRF) 8 neither
develop CD8a+ DC nor PDC (Schiavoni et al., 2002; Aliberti
et al., 2003; Tsujimura et al., 2003), whereas Batf3-deficient mice
are only deficient in CD8a+ DC (Hildner et al., 2008; Edelson
et al., 2010).
Amongst other receptors, the murine CD8a+ DC subset
expresses CD11c, CD24, CD36, Necl2, MHC-II, the integrin
CD103, the lectins CD205, CLEC9A, CLEC12A, and langerin
(CD207) (Shortman and Heath, 2010). CLEC9A and CD36 are
both involved in recognizing late apoptotic or necrotic cells
(Albert et al., 1998; Caminschi et al., 2008; Huysamen et al., 2008;
Sancho et al., 2009). Murine CD8a+ DC also express TLR3 and
TLR9 (Edwards et al., 2003), and respond to TLR stimulation
with proinflammatory IL-12 secretion and at least some type I
interferon production (Hochrein et al., 2001). Upon stimulation,
CD8a+ DC upregulate costimulatory markers CD40, CD80, and
CD86 as well as CD25, CD62L, and MHC-II (Wilson et al., 2003).
CD8a+ DC are most efficient in antigen cross-presentation, a
process in which extracellular antigen is not presented onMHC-II
to CD4+ T cells, but instead shunted to MHC-I with subsequent
induction of CD8+ T cells. Cross-presentation occurs through
the cytosolic or vacuolar pathway (Joffre et al., 2012). The former
involves proteasomal degradation with subsequent transport of
peptides into the endoplasmic reticulum via transporter associ-
ated with antigen processing 1 (TAP), whereas the latter is based
on lysosomal proteolysis with subsequent loading of peptides onto
MHC-I molecules (Joffre et al., 2012).
In this respect, CD8a+ DC, but not CD8a– DC, were shown
to cross-prime using a TAP-dependent pathway (den Haan et al.,
2000; Pooley et al., 2001; Schnorrer et al., 2006; Lin et al., 2008).
CD8a+ DC have been reported to selectively engulf dying cells
in vitro and in vivo and present on MHC-I via a proteasome-
dependent pathway (Iyoda et al., 2002; Schulz and Reis e Sousa,
2002). In these cells, endosomal acidification is limited (Savina
et al., 2009), which fosters limited antigen degradation and effi-
cient transport of the antigen to the cytosol (Delamarre et al.,
2005). Overexpression of MHC-I loading complexes (Dudziak
et al., 2007) by CD8a+ DC and expression of chemokine receptor
XCR1, whose ligand XCL1 is secreted by activated CD8+ T cells,
contribute to antigen cross-presentation and differentiation of
cytotoxic T cells (Dorner et al., 2009).
In HSV infections, CD8a+ DC are able to present viral
antigens and prime naïve CD4+ and CD8+ T cells, which appears
to be mediated by cross-presentation (Allan et al., 2003; Smith
et al., 2003; Belz et al., 2004a,b; Wilson et al., 2006; Bedoui et al.,
2009; Lee et al., 2009). It is still a matter of debate how the viral
antigen is transported from peripheral infected tissue to the
lymphoid-resident CD8a+ DC. In this process, mainly other
(migratory) DC are reported to be involved (Zhao et al., 2003;
Carbone et al., 2004; Allan et al., 2006; Bedoui et al., 2009; Jirmo
et al., 2009). These migratory DC either capture viral antigens
or are infected within the peripheral tissue, although reduced
migratory capacity has been reported for HSV-infected DC (Jones
et al., 2003; Eidsmo et al., 2009; Puttur et al., 2010). The transfer of
viral antigen can occur via exosomes, gap junctions, or uptake of
apoptotic material following death of migratory DC (Thery et al.,
2009; Mazzini et al., 2014). Another option is “crossdressing”, i.e.,
the transfer of preformedMHC-I complexes loaded with peptides
from infected cells to murine DC via secreted membrane vesicles
or transfer of membrane fragments (trogocytosis) (Thery et al.,
2009; Wakim and Bevan, 2011; Joffre et al., 2012).
Murine CD8a+ PDC: Cross-presentation
Help
Murine PDC were identified in the spleen of mice (Asselin-
Paturel et al., 2001; O’Keeffe et al., 2003). Amongst other sur-
face receptors, they express Ly6C, B220, and CD11c. Upon
stimulation, type I interferons—and to a minor extent IL-
12—are induced, and costimulatory markers CD40, CD69,
CD80, and CD86 are upregulated (Asselin-Paturel et al., 2001;
O’Keeffe et al., 2002; Lund et al., 2003). Unstimulated murine
PDC express CD8a only to a minor extent, while expo-
sure to CpG or viruses enhances expression of this molecule
(Nakano et al., 2001; O’Keeffe et al., 2002, 2003). When CD8a+
and CD8a– PDC were separated and subsequently stimulated,
they did not differ in cytokine production (O’Keeffe et al.,
2002).
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A few publications report TAP-dependent cross-presentation
of soluble and particulate antigen by murine PDC after TLR liga-
tion (Shinohara et al., 2006;Mouries et al., 2008; Kool et al., 2011).
The majority of authors, however, deny cross-presentation by
murine PDC (Chung et al., 2005; Janssen et al., 2006; Sapoznikov
et al., 2007; GeurtsvanKessel et al., 2008; Reboulet et al., 2010;
Hennies et al., 2011). In vitro stimulation of murine PDC with
HSV-1 or influenza allowed priming of CD8+ T cells (Belz
et al., 2004a). In in vivo HSV-1 infections, however, PDC do not
participate in active cross-presentation (Allan et al., 2003; Lee
et al., 2009; Swiecki et al., 2013). Still, murine PDC appear to
be important in enhancing cross-presentation by other DC. An
explanation of this phenomenon could be that type I interferons
increase cross-presentation by decreasing antigen degradation in
endocytic compartments and stimulating the survival of CD8a+
DC (Diamond et al., 2011; Fuertes et al., 2011; Lorenzi et al., 2011).
In this respect, depletion of murine PDC was reported to impair
CTL-mediated HSV-1 eradication in a CD2-, CD40L-, and type
I interferon-dependent manner (Yoneyama et al., 2005). Also in
the lymphocytic choriomeningitis model, virus-induced type I
interferons were required for cross-priming of CD8+ T cells (Le
Bon et al., 2003). When PDC were depleted in CLEC4C-DTR
mice, PDC proved to be important for inducing CD8+ T cell
responses in systemic HSV-1 andHSV-2 infections (Swiecki et al.,
2013). Further functions of PDC in murine HSV-1 and HSV-2
infections are reviewed in (Schuster et al., 2011).
Human Orthologue of CD8a+ DC:
Cross-presentation Following Activation
The conventional human blood DC population consist of three
subsets specifically expressing CD1c (BDCA1), CD16, or CD141
(BDCA3) (Dzionek et al., 2000;MacDonald et al., 2002). Evidence
is accumulating that the CD11c+ CD141+ DC subset represents
the human orthologue of murine CD8a+ DC. These cells can be
detected in lymphatic tissues such as lymph nodes, tonsils, bone
marrow, spleen, and also liver (Galibert et al., 2005; Lindstedt
et al., 2005; Velasquez-Lopera et al., 2008; Bamboat et al., 2009;
Poulin et al., 2010). Genome-wide expression analyses revealed
a similar transcriptomal signature between CD141+ human DC
and murine CD8a+ DC (Robbins et al., 2008). Both subsets
express Necl2 (Galibert et al., 2005), CLEC9A (Caminschi et al.,
2008; Huysamen et al., 2008; Sancho et al., 2009; Jongbloed
et al., 2010; Schreibelt et al., 2012), TLR3 (Edwards et al., 2003;
Lindstedt et al., 2005; Jongbloed et al., 2010), as well as CD207,
Batf3, and IRF8 (Poulin et al., 2010). BDCA3+ DC also express
the chemokine receptor XCR1 and respond to respective ligands
(Bachem et al., 2010; Crozat et al., 2010). Similar to murine
CD8a+ DC, human BDCA3+ DC respond to TLR3 ligation with
production of lambda interferons (Lauterbach et al., 2010). In
contrast to murine CD8a+ DC, human BDCA3+ DC do not
express TLR9 (Jongbloed et al., 2010).
Lymphoid tissue-derived human BDCA3+ DC were shown
to be at least equivalent to other human DC subsets in cross-
presenting soluble or cell-associated antigens, even in the absence
of activation (Segura et al., 2012, 2013). This process can be
enhanced by stimulation with TLR3 ligands, inducing superior
cross-presenting activity by blood-derived BDCA3+ DC with
induction of CD8+ T cell responses (Poulin et al., 2007; Bachem
et al., 2010; Crozat et al., 2010; Jongbloed et al., 2010). There
is evidence that cross-presentation by myeloid DC plays a role
in human herpes virus infections (Bosnjak et al., 2005), but the
importance of BDCA3+ DC needs to be further clarified.
Human CD8a+ PDC: Cross-presentation
Help Following Viral Activation?
In 1999, two independent groups identified human PDC as major
producers of type I interferons in the blood (Cella et al., 1999;
Siegal et al., 1999). Amongst other receptors, PDC express BDCA2
and BDCA4, MHC-II, the lymph node-homing receptors CD62L
and CCR7 (CD197), and costimulatory molecules (CD40, CD80,
CD86, CD270, CD274, CD275) (Cella et al., 2000; Dzionek et al.,
2000; Ito et al., 2007; Jaehn et al., 2008; Donaghy et al., 2009;
Schuster et al., 2010, 2011; Cabezon et al., 2011). PDC recognize
single-stranded RNA and CpG molecules via TLR7 and TLR9,
respectively (Kadowaki et al., 2001).
Whether human PDC can cross-present soluble or particu-
late antigens is still a matter of debate. Viral antigen derived
from influenza, recombinant vaccinia, tick-borne encephalitis or
human immunodeficiency type I virus infection was taken up
into recycling endosomes, loaded onto MHC-I molecules, and
presented to CD8+ T cells (Fonteneau et al., 2003a,b; Hoeffel
et al., 2007; Di Pucchio et al., 2008; Lui et al., 2009; Mittag et al.,
2011; Tel et al., 2012). In addition, antigen loaded on synthetic
microparticles or soluble tumor-associated antigen was presented
to CD8+ T cells by exposed PDC (Tel et al., 2010; Guillerme et al.,
2013; Segura et al., 2013). In contrast, other groups report no or
only minor cross-presenting capacities of human PDC (Schnurr
et al., 2005; Bachem et al., 2010; Crozat et al., 2010).
An early report by Fitzgerald-Bocarsly described the
“interferon-producing cells” as being important for the lysis
of HSV-infected fibroblasts (Feldman et al., 1992). PDC infiltrate
herpetic lesions in the genital tract and tightly colocalize
with NK and T cells (Donaghy et al., 2009). HSV-stimulated
human PDC induce migration of activated T and NK cells via
chemokine secretion (Megjugorac et al., 2004), and contribute
to the activation of NK cells via IFNa- and TNFa-dependent
mechanism (Vogel et al., 2014). In addition, HSV-exposed PDC
were shown to prime IL-10 and IFN-g production by cytotoxic
regulatory CD4+ T cells (Kadowaki et al., 2000; Kawamura et al.,
2006).
So far, expression of CD8 on human PDC has not been
reported. Since the expression of this molecule on the surface
of human PDC may define new and yet unknown capacities
of these cells, we investigated whether PDC might upregulate
these molecules upon viral stimulation. Recently, we analyzed
the expression profile of human PDC, which were purified from
PBMC of six donors. After exposure to IL-3 or IL-3 plus UV-
inactivated HSV-1 (HSVUV), RNA was extracted from these
cells and hybridized to a Human Genome U133 Plus 2_0 Array
(Affymetrix, Santa Clara, CA, USA) (Schuster et al., 2010). In
these analyses, we focused on the expression and regulation of sur-
face receptors on PDC. Notably, the signal for CD8a expression
Frontiers in Microbiology | www.frontiersin.org June 2015 | Volume 6 | Article 5573
Schuster et al. Human HSV-exposed PDC express CD8a
FIGURE 1 | Characterization of CD8a-expressing human plasmacytoid
dendritic cells (PDC). (A) Expression of CD8a on human PDC, as evaluated
by flow cytometry within PBMC immediately after cell isolation (0 h) (n = 9) and
after cultivation of purified PDC in the presence of IL-3 (10 ng/ml), IL-3 plus
UV-inactivated herpes simplex virus type 1 (HSVUV) (n = 16) or infectious
HSV-1 (HSVINF) (n = 6) (1  106 plaque-forming units/ml) for 40 h. One
representative example of PDC exposed to IL-3 (upper left panel) and IL-3 plus
HSVUV (lower left panel) and data of all donors including mean values (bars) are
shown (right panel). (B) Representative expression of CD8a, not CD8b, on
human PDC after exposure to IL-3 plus HSVUV (upper panel, n = 4) or HSVINF
(lower panel, n = 3) for 40 h. (C) Kinetics of CD8a (n = 4) and CD8b (n = 3)
expression after exposure of human PDC to IL-3 or IL-3 plus HSVUV for
4 days. Data are presented as mean and standard deviation. (D) Expression of
markers for costimulation (CD40, CD274), activation (CD69), maturation
(CD83), and migration (CD197) on CD8a+ and CD8a  human PDC after
exposure to IL-3 plus HSVUV for 40 h. The dotted lines represent isotype
controls. For statistical analysis, MFI values were transformed logarithmically to
obtain normal distribution. Expression of CD4 as well as CD2, CD46, CD80,
and CD123 (data not shown) was not significantly different between the two
PDC subsets. Mean and standard deviation of four different donors (except for
CD274, n = 3). (E) After stimulation of human PDC with IL-3 plus HSVUV for
40 h, cells were harvested and then separated using a CD8 cell isolation kit
(Miltenyi Biotec, Bergisch-Gladbach, Germany). After stimulation with IL-3 or
IL-3 plus HSVUV for another 20 h, different cytokines were analyzed in the cell
culture supernatants using a multiplex cytokine and chemokine panel on a
luminex platform (Invitrogen/Life Technologies, Darmstadt, Germany, and
Affymetrix/ebioscience, Frankfurt, Germany). Mean and standard deviation of
three different donors. *p < 0.05, **p < 0.01, ***p < 0.001.
increased from 57.2 to 100.1, which was slightly above the arbi-
trary threshold of 95, reflecting the expression signal of TLR9. In
contrast, three probe sets forCD8b remained below this threshold.
These data suggested a potential expression of CD8a on PDC
upon stimulation with HSVUV.
To corroborate these data, we isolated PDC from a total of 15
different donors, and investigated CD8a expression on these cells
in independent experiments after exposure to IL-3 (n = 16), IL-
3 plus HSVUV (n = 16), or IL-3 plus infectious HSV-1 (HSVINF,
n = 6) for 40 h. Flow cytometry confirmed a distinct expres-
sion of CD8a on a subset of HSVUV- and HSVINF-exposed PDC
(Figure 1A). After stimulation with HSVUV or HSVINF, the per-
centage of CD8a-expressing PDC was significantly higher com-
pared to PDC within freshly isolated PBMC (n = 9) (p < 0.001
for HSVUV and p< 0.05 for HSVINF, unpaired t-test) and purified
PDC that were cultivated in the presence of IL-3 only (p < 0.001
for HSVUV and p < 0.05 for HSVINF, paired t-test) (Figure 1A).
CD8a expressionwas not different betweenHSVUV- andHSVINF-
exposed PDC (p = 0.27, n.s.). When we stained in parallel for
CD8a and CD8b expression, we confirmed expression of CD8a
by flow cytometry, while CD8b was neither detected on PDC
exposed toHSVUV (n= 4) norHSVINF (n= 3) (Figure 1B). These
data indicated that PDC did not express a heterodimeric CD8ab
receptor upon stimulation. In further analyses, we investigated the
kinetics of CD8a expression (n = 4). After exposure to HSVUV,
the percentage of CD8a-expressing cells increased by day 1, but
reached significance by day 2 post stimulation, compared to PDC
cultivated with IL-3 alone (n < 0.05, paired t-test). Expression of
CD8b was not detected at any of the time points analyzed (n= 3)
(Figure 1C).
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To find out in how far CD8a+ and CD8a– PDC differed from
each other, we analyzed the expression of cell surface markers
for costimulation (CD40, CD274), activation (CD69), matura-
tion (CD83), and migration (CD197) on these two subsets. All
these markers were significantly upregulated on CD8a+ PDC
compared to CD8a– PDC (p < 0.05, paired t-test) (Figure 1D),
while five other surface molecules (CD2, CD4, CD46, CD80, and
CD123) were not differently regulated after HSVUV stimulation.
These data suggested that the subset of CD8a+ PDC was partic-
ularly activated. Eventually, we exposed PDC of three donors to
HSVUV for 40 h, separated these cells using aCD8 cell isolation kit,
and exposed the CD8a+ and CD8a– PDC to HSVUV for another
20 h. Subsequently, cell culture supernatants were analyzed using a
multiplex cytokine bead assay. Of a total of 25 cytokines, we found
IFN-a, IL-8, IL-1RA, MIP-1a, MIP-1b, and MCP-1 upregulated
in CD8a-expressing PDC. In contrast, IL-6 secretion was not
different between the two subsets, and other cytokines were either
not induced (IL-1b, IL-17, IFN-g, GM-CSF, MIG, RANTES) or
expressed only at very low levels (IL-2, IL-4, IL-5, IL-7, IL-12p40,
IL-13, IL-15, eotaxin) (Figure 1E). IFN-a and IL-6 enhance T cell,
B cell, and NK cell development and function; IL-8 recruits T cells
and induces their degranulation; IL-1RA inhibits IL-1 induced T
cell activation, and the chemokines MIP-1a, MIP-1b, and MCP-
1 recruit immature DC, monocytes, and Th1 cells. Altogether,
these data indicate that a subset of PDC gradually upregulates a
homodimeric CD8a receptor upon HSV-1 stimulation, exposes a
highly activated phenotype, and appears to be particularly active
in recruiting other immune cells to the site of inflammation.
Conclusion
This is—at least to our knowledge—the first report that a subset
of human PDC is capable of expressing CD8a at the cell surface
upon HSV-1 stimulation. This subset is phenotypically different
from the CD8a– PDC in expressing increased levels of markers
for activation, costimulation, and migration. In parallel, CD8a+
PDC secrete enhanced levels of proinflammatory cytokines and
chemokines. Therefore, this subset may play an important role in
innate and adaptive immune defenses in HSV-1 infections. So far,
it is unclear whether CD8a+ PDC are just amore activated subset,
which “does better” than CD8a– PDC, or whether they have
additional or different functions, such as being actively involved
in cross-presentation. Further studies are required to define the
conditions under which PDC present antigen efficiently and
which formulation of antigen fits best for PDC cross-presentation
(Villadangos and Young, 2008). Notably, murine knockouts for
IRF8 lead to deficiencies in PDC and lymphoid-resident CD8a+
DC (Schiavoni et al., 2002; Aliberti et al., 2003; Tsujimura et al.,
2003). This phenomenonmay point to a common link in develop-
ment and possibly function of these two cell populations. Further
analyses of human CD8a-expressing PDCwill delineate their role
in the defense against viral infections, and—if viral vectors are
used—also in anti-tumor responses.
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